한글목차

의약품 등급 셀룰로오스 분말 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 15억 5,000만 달러에서 2026년에는 16억 5,000만 달러에 이르고, CAGR 6.1%로 성장할 전망입니다. 지난 수년간의 성장은 경구용 의약품 제제 증가, 셀룰로오스 첨가제의 보급, 의약품 제조의 확대, 제제 안정성에 대한 수요, 셀룰로오스계 첨가제의 규제 승인 등의 요인에 기인하는 것으로 보입니다.

의약품 등급 셀룰로오스 분말 시장 규모는 향후 몇 년간 견고성장이 전망됩니다. 2030년에는 20억 9,000만 달러에 이르고, CAGR은 6.1%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 영양 보충제 응용 분야 확대, 클린 라벨 첨가제에 대한 수요 증가, 제네릭 의약품 파이프라인 확대, 첨가제 공학의 발전, 지속가능성 요구 사항 증가 등이 있습니다. 예측 기간의 주요 동향으로는 식물 유래 의약품 첨가제에 대한 수요 증가, 경구용 고체 제형 사용 확대, 미결정성 셀룰로오스 채택 증가, 다기능성 셀룰로오스 첨가제 확대, 지속 가능한 첨가제 조달에 대한 집중 강화 등을 들 수 있습니다.

향후 몇 년 동안 의약품 생산량 증가는 의약품 등급 셀룰로오스 분말 시장의 성장을 주도할 것으로 예측됩니다. 의약품 생산에는 의약품의 안전성, 유효성, 규제 기준 적합성을 확보하기 위해 유효성분과 첨가제의 처방 설계, 합성, 품질관리가 포함됩니다. 장기적인 약물 복용을 필요로 하는 만성질환 증가가 의약품 생산 확대에 기여하고 있습니다. 제약 등급 셀룰로오스 분말은 신뢰할 수 있는 결합제, 충전제 및 안정제 역할을 하여 정제의 무결성을 유지하고 약물의 균일한 분포를 보장함으로써 이 생산을 지원합니다. 예를 들어, 2023년 6월 유럽제약협회(EFPIA)의 데이터에 따르면 유럽의 제약 총생산액은 2023년 4,228억 300만 달러(3,900억 유로)로 2022년 3,938억 5,700만 달러(3,633억 유로)에서 증가하였습니다. 그 결과, 의약품 생산 증가는 의약품 등급 셀룰로오스 분말 시장의 성장을 가속하고 있습니다.

제약용 셀룰로오스 분말 시장에서 사업을 영위하는 주요 기업들은 생산 능력 확대와 제약 첨가제 공급망 역량 강화를 위해 새로운 미결정 셀룰로오스(MCC) 시설 개발에 주력하고 있습니다. MCC 시설은 정제된 셀룰로오스를 제어된 화학적, 기계적 처리를 통해 균일하고 미세한 의약품용 입자를 생산하는 전문 플랜트입니다. 예를 들어, 2023년 9월 인도의 첨가제 제조업체인 Nitika Pharmaceuticals Specialties는 나그푸르에 인도 최대 규모의 MCC 제조 공장인 'Tabcell'을 설립했습니다. 첨단 기술력과 연간 1,200톤의 생산 능력을 갖춘 이 공장은 니틴 가드칼리(Nitin Gadkari) 연방 장관이 개소식을 가졌으며, 인도 정부의 첨가제 생산 연동형 장려금(PLI) 제도의 중요한 이정표가 되었습니다. 이 시설을 통해 니티카제약은 의약품 첨가제 분야의 세계 리더로서의 입지를 강화하고, 국내 수요와 92개국 이상에 대한 수출을 지원하는 동시에 '메이크 인 인디아(Make in India)' 계획을 지원하며 지역 내 중요한 고용 기회를 창출하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharma grade cellulose powder is a purified, plant-derived material manufactured to meet strict pharmaceutical quality standards. It is widely used as an excipient in drug formulations. Its chemically inert, non-toxic, and stable nature ensures compatibility with active pharmaceutical ingredients (APIs) and improves the uniformity and production efficiency of oral solid dosage forms.

The main types of pharma grade cellulose powder include microcrystalline cellulose (MCC), carboxymethyl cellulose (CMC), hydroxypropyl methylcellulose (HPMC), and hydroxypropyl cellulose (HPC). Microcrystalline cellulose (MCC) is a stable, compressible derivative of wood pulp extensively used in pharmaceuticals as a binder, filler, and disintegrant due to its excellent flow and direct compression properties. It serves multiple functions such as a binding agent, thickener, stabilizer, disintegrant, and coating agent across applications including pharmaceuticals, nutraceuticals, cosmetics, and others. It is utilized by a range of end users, including contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutions, dietary supplement manufacturers, and the food and beverage industry.

Tariffs have impacted the pharma grade cellulose powder market by increasing the cost of imported raw cellulose and specialized processing equipment used in excipient production. These impacts are most pronounced in pharmaceutical and nutraceutical manufacturing regions across North America, Europe, and Asia Pacific, where excipient supply chains are globally integrated. Rising tariff related expenses have contributed to higher excipient prices and margin pressure for manufacturers. This has influenced procurement strategies and formulation cost structures for drug and supplement producers. However, tariffs have promoted regional sourcing, localized excipient processing, and stronger long term supply chain resilience.

The pharma grade cellulose powder market research report is one of a series of new reports from The Business Research Company that provides pharma grade cellulose powder market statistics, including pharma grade cellulose powder industry global market size, regional shares, competitors with a pharma grade cellulose powder market share, detailed pharma grade cellulose powder market segments, market trends and opportunities, and any further data you may need to thrive in the pharma grade cellulose powder industry. This pharma grade cellulose powder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma grade cellulose powder market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growth in oral drug formulations, widespread use of cellulose excipients, expansion of pharmaceutical manufacturing, demand for formulation stability, regulatory acceptance of cellulose-based excipients.

The pharma grade cellulose powder market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to growth in nutraceutical applications, rising demand for clean-label excipients, expansion of generic drug pipelines, advancements in excipient engineering, increasing sustainability requirements. Major trends in the forecast period include rising demand for plant-based pharmaceutical excipients, increasing use in solid oral dosage forms, growing adoption of microcrystalline cellulose, expansion of multi-functional cellulose excipients, increasing focus on sustainable excipient sourcing.

The increasing pharmaceutical production is expected to drive the growth of the pharma-grade cellulose powder market in the coming years. Pharmaceutical production involves the formulation, synthesis, and quality control of active ingredients and excipients to ensure medicines are safe, effective, and compliant with regulatory standards. The rise in chronic diseases, which require long-term and continuous medication, is contributing to the growth of pharmaceutical production. Pharma-grade cellulose powder supports this production by acting as a reliable binder, filler, and stabilizer, maintaining tablet integrity and ensuring uniform drug distribution. For example, in June 2023, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the European pharmaceutical industry, reported that total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, up from $393,857 million (€363,300 million) in 2022. Consequently, the rising pharmaceutical production is boosting the growth of the pharma-grade cellulose powder market.

Major companies operating in the pharma-grade cellulose powder market are focusing on developing new microcrystalline cellulose (MCC) facilities to expand production capacity and strengthen supply chain capabilities for pharmaceutical excipients. An MCC facility is a specialized plant where purified cellulose undergoes controlled chemical and mechanical processes to produce uniform, fine-grade particles for pharmaceutical applications. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturer, inaugurated Tabcell, India's largest MCC manufacturing plant in Nagpur. Equipped with advanced technology and an installed capacity of 1,200 metric tons, the plant was inaugurated by Union Minister Nitin Gadkari and represents a key milestone under the Government of India's Production Linked Incentive (PLI) scheme for excipients. This facility enhances Nitika Pharma's position as a global leader in pharmaceutical excipients, serving both domestic demand and exports to over 92 countries, while also supporting the "Make in India" initiative and generating significant local employment opportunities.

In December 2024, Nordic Bioproducts Group, a Finland-based manufacturer of MCC, partnered with C.Q. Masso to expand the supply of sustainable microcrystalline cellulose for the beauty and personal care sector. This collaboration aims to help manufacturers meet evolving EU regulations on harmful ingredients and product traceability by providing MCC, a renewable, wood-derived alternative to materials such as talc and titanium dioxide. The partnership supports the industry's shift toward safer, environmentally responsible formulations while ensuring a reliable and traceable supply chain across Europe. C.Q. Masso is a Spain-based company that produces chemical specialties across multiple sectors.

Major companies operating in the pharma grade cellulose powder market are Roquette Freres, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma grade cellulose powder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma-grade cellulose powder market consists of sales of sodium carboxymethyl cellulose and cellulose acetate phthalate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Grade Cellulose Powder Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharma grade cellulose powder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma grade cellulose powder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharma grade cellulose powder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Microcrystalline Cellulose (MCC); Carboxymethyl Cellulose (CMC); Hydroxypropyl Methylcellulose (HPMC); Hydroxypropyl Cellulose (HPC)
• 2) By Functionality: Binding Agent; Thickening Agent; Stabilizer; Disintegrant; Coating Agent
• 3) By Application: Pharmaceuticals; Nutraceuticals; Cosmetics; Other Applications
• 4) By End-User: Contract Research Organizations (CROs); Pharmaceutical and Biotechnology Companies; Academic And Research Institutions; Manufacturers Of Dietary Supplements; Food And Beverage Industries
• Subsegments:
• 1) By Microcrystalline Cellulose: Powder; Granules
• 2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC); Calcium Carboxymethyl Cellulose (CMC); Other Carboxymethyl Cellulose (CMC) Variants
• 3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC); Medium Viscosity Hydroxypropyl Methylcellulose (HPMC); High Viscosity Hydroxypropyl Methylcellulose (HPMC)
• 4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC); High Substitution Hydroxypropyl Cellulose (HPC)
• Companies Mentioned: Roquette Freres; Ashland Global; JRS Pharma; DFE Pharma; Sigachi Industries Ltd.; Accent Microcell Ltd.; FMC Corporation; Dow Chemical Company; Shin-Etsu Chemical Co. Ltd.; Colorcon; Nippon Paper Industries Co. Ltd.; Rayonier Advanced Materials; Lotte Fine Chemical; Mingtai Chemical Co. Ltd.; Weifang Lude Chemical Co. Ltd.; Shandong Head Co. Ltd.; Zhejiang Kehong Chemical Co. Ltd.; Anhui Sunhere Pharmaceutical Excipients Co. Ltd.; Maple Biotech Pvt. Ltd.; Ankit Pulps & Boards Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharma Grade Cellulose Powder Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharma Grade Cellulose Powder Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharma Grade Cellulose Powder Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharma Grade Cellulose Powder Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Industry 4.0 & Intelligent Manufacturing
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Biotechnology, Genomics & Precision Medicine
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Plant-Based Pharmaceutical Excipients
  • 4.2.2 Increasing Use In Solid Oral Dosage Forms
  • 4.2.3 Growing Adoption Of Microcrystalline Cellulose
  • 4.2.4 Expansion Of Multi-Functional Cellulose Excipients
  • 4.2.5 Increasing Focus On Sustainable Excipient Sourcing

5. Pharma Grade Cellulose Powder Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations
• 5.4 Dietary Supplement Manufacturers
• 5.5 Food And Beverage Industries

6. Pharma Grade Cellulose Powder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharma Grade Cellulose Powder Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharma Grade Cellulose Powder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharma Grade Cellulose Powder Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharma Grade Cellulose Powder Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharma Grade Cellulose Powder Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharma Grade Cellulose Powder Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharma Grade Cellulose Powder Market Segmentation

• 9.1. Global Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)
• 9.2. Global Pharma Grade Cellulose Powder Market, Segmentation By Functionality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent
• 9.3. Global Pharma Grade Cellulose Powder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications
• 9.4. Global Pharma Grade Cellulose Powder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries
• 9.5. Global Pharma Grade Cellulose Powder Market, Sub-Segmentation Of Microcrystalline Cellulose, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Powder, Granules
• 9.6. Global Pharma Grade Cellulose Powder Market, Sub-Segmentation Of Carboxymethyl Cellulose (CMC), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants
• 9.7. Global Pharma Grade Cellulose Powder Market, Sub-Segmentation Of Hydroxypropyl Methylcellulose (HPMC), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)
• 9.8. Global Pharma Grade Cellulose Powder Market, Sub-Segmentation Of Hydroxypropyl Cellulose, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

10. Pharma Grade Cellulose Powder Market Regional And Country Analysis

• 10.1. Global Pharma Grade Cellulose Powder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharma Grade Cellulose Powder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharma Grade Cellulose Powder Market

• 11.1. Asia-Pacific Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharma Grade Cellulose Powder Market

• 12.1. China Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharma Grade Cellulose Powder Market

• 13.1. India Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharma Grade Cellulose Powder Market

• 14.1. Japan Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharma Grade Cellulose Powder Market

• 15.1. Australia Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharma Grade Cellulose Powder Market

• 16.1. Indonesia Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharma Grade Cellulose Powder Market

• 17.1. South Korea Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharma Grade Cellulose Powder Market

• 18.1. Taiwan Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharma Grade Cellulose Powder Market

• 19.1. South East Asia Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharma Grade Cellulose Powder Market

• 20.1. Western Europe Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharma Grade Cellulose Powder Market

• 21.1. UK Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharma Grade Cellulose Powder Market

• 22.1. Germany Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharma Grade Cellulose Powder Market

• 23.1. France Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharma Grade Cellulose Powder Market

• 24.1. Italy Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharma Grade Cellulose Powder Market

• 25.1. Spain Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharma Grade Cellulose Powder Market

• 26.1. Eastern Europe Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharma Grade Cellulose Powder Market

• 27.1. Russia Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharma Grade Cellulose Powder Market

• 28.1. North America Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharma Grade Cellulose Powder Market

• 29.1. USA Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharma Grade Cellulose Powder Market

• 30.1. Canada Pharma Grade Cellulose Powder Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharma Grade Cellulose Powder Market

• 31.1. South America Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharma Grade Cellulose Powder Market

• 32.1. Brazil Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharma Grade Cellulose Powder Market

• 33.1. Middle East Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharma Grade Cellulose Powder Market

• 34.1. Africa Pharma Grade Cellulose Powder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharma Grade Cellulose Powder Market, Segmentation By Product Type, Segmentation By Functionality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharma Grade Cellulose Powder Market Regulatory and Investment Landscape

36. Pharma Grade Cellulose Powder Market Competitive Landscape And Company Profiles

• 36.1. Pharma Grade Cellulose Powder Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharma Grade Cellulose Powder Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharma Grade Cellulose Powder Market Company Profiles
  • 36.3.1. Roquette Freres Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Ashland Global Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. JRS Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. DFE Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sigachi Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Pharma Grade Cellulose Powder Market Other Major And Innovative Companies

• Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

38. Global Pharma Grade Cellulose Powder Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharma Grade Cellulose Powder Market

40. Pharma Grade Cellulose Powder Market High Potential Countries, Segments and Strategies

• 40.1 Pharma Grade Cellulose Powder Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharma Grade Cellulose Powder Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharma Grade Cellulose Powder Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer